Keywords: aeterna, 1st, qtr, sales, leap, canada, laboratories
AEterna 1st qtr sales leap 61.3%
Article | 05 May 2003
Canada's AEterna Laboratories has reported consolidated revenues for thefirst quarter ended March 31 of C$40.8 million ($28.2 million), up 61.3%, and a net ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
